Final Report: Validation and Evaluation of Biomarkers in Workers Exposed to Benzene in ChinaEPA Grant Number: R828112C115
Subproject: this is subproject number 115 , established and managed by the Center Director under grant R828112
(EPA does not fund or establish subprojects; EPA awards and manages the overall grant for this center).
Center: Health Effects Institute (2000 — 2005)
Center Director: Greenbaum, Daniel S.
Title: Validation and Evaluation of Biomarkers in Workers Exposed to Benzene in China
Investigators: Qu, Qingshan
Institution: New York University Medical Center , Health Effects Institute
EPA Project Officer: Chung, Serena
Project Period: April 1, 2000 through March 31, 2005
RFA: Health Effects Institute (1996) RFA Text | Recipients Lists
Research Category: Health Effects , Air Quality and Air Toxics , Air
Human exposure to benzene is widespread because it is a component of gasoline and also is used extensively as an industrial solvent. Exposure to high levels of benzene is associated with development of leukemia and other blood disorders, but the risks of exposure to low levels of benzene are not well understood. In the 1990s, the Health Effects Institute (HEI) initiated a research program designed to study the effects of exposure to toxic air pollutants at ambient levels. The biomarkers of recent exposure were urinary metabolites (measuring responses up to hours after exposure) and adducts of blood proteins (days to weeks after exposure). The biomarkers of longer-term exposure were chromosomal changes, integrating exposure over months to years. Because chromosomal changes may be determinants of subsequent health effects, they also may be considered early biomarkers of benzene effect. Chromosomal changes also may be due to causes other than exposure to benzene.
To validate the biomarkers characterized in these studies, another part of the research program, solicited applications from investigators with access to suitable human populations exposed to benzene or butadiene. HEI funded a study by Dr Qingshan Qu of New York University School of Medicine to evaluate putative biomarkers in workers occupationally exposed to benzene in China.
Qu and colleagues recruited 181 healthy workers in several factories in the Tianjin region of China. These subjects formed part of a cohort of thousands identified by the U.S. National Cancer Institute (NCI) and the China Academy of Preventive Medicine for a study to evaluate tumor incidence in benzene exposed workers (NCI/China study). In phase 1 of their study, Qu and colleagues evaluated the suitability of using urinary metabolites, blood adducts, or chromosomal aberrations in polymorphonuclear leukocytes and lymphocytes as benzene biomarkers in 25 heavily exposed and 25 unexposed workers. The urinary metabolites measured were phenol, catechol, hydroquinone, benzene triol, S-phenylmercapturic acid (S-PMA), and trans,trans-muconic acid (t,t-MA). The blood adducts measured were benzene oxide and benzoquinone adducts of albumin.
In phase 2, the investigators used biomarkers validated in phase 1 of the study to evaluate relations between benzene exposures and levels of these biomarkers in another 105 benzene-exposed workers and 26 unexposed workers. The investigators focused on obtaining samples from workers whose current day exposures to benzene were no more than 5 ppm, representing the low end of occupational exposure. Qu and colleagues also evaluated whether the number and type of blood cells decreased in the exposed subjects because such decreases may be early indicators of a response to occupational benzene exposure. Some biological samples were analyzed in China and some in the United States.
This study made important contributions regarding the utility of biomarkers of benzene exposure in occupational settings. It is the first to evaluate multiple possible biomarkers of benzene across a wide range of exposures and to show effects at the lowest end of the range. In addition to using sensitive assays for urinary metabolites and blood adducts, Qu and colleagues made great efforts to accurately measure and monitor personal exposures to a wide range of benzene levels in the workplace—critical features for assessing the accuracy of biomarker information. The investigators also paid careful attention to quality control issues.
The study’s most novel finding was that benzene exposure was associated with decreases in the numbers of circulating neutrophils and, to a lesser extent, lymphocytes. The decrease in neutrophil numbers is interesting because long-term human exposure to high levels of benzene has been previously associated with the development of cancer in bone marrow precursor cells that give rise to neutrophils. This result—indicating that changes in neutrophil numbers may be a sensitive marker of benzene effects—needs to be corroborated, however, because other studies have found changes in lymphocyte, but not neutrophil, numbers.
A key positive feature of the study design was Qu’s two-step approach to validating possible biomarkers in phase 1 before proceeding to the larger study in phase 2. The phase 1 results indicated that S-PMA and t,t-MA, minor metabolites of benzene found in urine, might be the most useful markers of recent benzene exposure. Combined analysis of phase 1 and 2 results confirmed the suitability of S-PMA and t,t-MA as biomarkers for this purpose: both markers had low background levels in unexposed workers and increased levels in exposed workers. S-PMA was found to be the most useful biomarker for recent exposure to benzene because of the extent of the change in its level, its sensitivity in correlating with low occupational benzene exposures, and its specificity for benzene exposure. The urinary metabolites phenol, hydroquinone, and catechol were less sensitive to changes in benzene exposure and had higher background levels than S-PMA and t,t-MA. Therefore, these markers were less suitable for detecting dose-dependent variation across the spectrum of benzene exposures. Benzene triol was found to be unsuitable as a biomarker.
Exposure-dependent changes in blood adduct levels (half-life in blood of approximately 14 days) were found to be suitable measures for evaluating recent exposure although the background levels in unexposed workers were quite high.
Using the fluorescence in situ hybridization (FISH) technique to examine specific chromosomes for effects of longer-term benzene exposure, the investigators did not detect differences between the numbers of chromosomal aberrations in exposed and unexposed workers. In contrast, FISH data in the NCI/China study evaluating the same chromosome (chromosome 7) showed increased numbers of aberrations in exposed workers. However, differences in cell culture conditions, probes evaluated, and scoring criteria make it difficult to compare the FISH results between the two studies. In addition, the overall frequencies of numerical aberrations (hyperdiploidy) reported in the unexposed control subjects participating in the NCI/China study were unusually high, which complicates comparisons. Although the median exposures of workers in the NCI/China and HEI studies were similar, workers in the NCI study with above-median exposures were exposed to much higher benzene levels than those participating in the HEI study. These higher exposures also may have contributed to the differences between the FISH results of the two studies. Using conventional cytogenetic techniques to evaluate all chromosomes, Qu and colleagues found some increases in aberrations in exposed workers compared with controls. These increases were difficult to interpret because they were not linear with recent changes in benzene exposure. A more consistent exposure-response relationship was seen, however, when the aberration frequencies were categorized by cumulative benzene exposures.
The investigators evaluated exposure-response effects in the phase 2 subjects combined with the subjects who had been evaluated in phase 1, which was conducted in the previous year. Combined analysis of phase 1 and phase 2 results may have introduced unmeasured confounding because exposures in the 2 phases were measured in different years and at different sites. Further, they used different subjects with much lower exposure levels—by design—in phase 2 than phase 1. Although Qu and colleagues amply addressed many aspects of this issue in the report, the validity of combining data from phases 1 and 2 of the study remains uncertain.
In conclusion, Qu and colleagues’ study has validated several biomarkers. Urinary levels of S-PMA appear to be the most useful measure of exposure to benzene (detecting changes within a few hours). Blood adducts of benzene and albumin may be useful biomarkers of exposure within days to weeks, but background levels of these adducts are quite high in people not exposed to benzene. Finally, the investigators found that changes in neutrophil levels may be a sensitive and early marker of benzene’s toxicity, but further research is needed to confirm this last finding.
Aksoy M. 1988a. Benzene carcinogenicity. In: M Aksoy, ed. Benzene Carcinogenicity. Boca Raton FL: CRC Press, pp. 113–144.
Aksoy M. 1988b. Benzene hematotoxicity. In: M Aksoy, ed. Benzene Carcinogenicity. Boca Raton FL: CRC Press, pp. 59–104.
Aksoy M, Dincol K, Akgun T, Erdem S, Dincol G. 1971. Hematological effects of chronic benzene poisoning in 217 workers. Br J Ind Med 28:296–302.
Aksoy M, Ozeris S, Sabuncu H, Yanardag R. 1987. Exposure to benzene in Turkey between 1983 and 1985: a hematologic study on 231 workers. Br J Ind Med 44:785–787.
Andrews LS, Lee EW, Witmer CM, Kocsis JJ, Snyder R. 1977. Effects of toluene on the metabolism, disposition and hemopoietic toxicity of [3H]benzene. Biochem Pharmacol 26:293–300.
Baselt RC. 1980. Biological Monitoring Methods for Industrial Chemicals. Davis, CA: California Biomedical Publication, pp. 37–42.
Bechtold WE, Henderson RF. 1993. Biomarkers of human exposure to benzene. J Toxicol Environ Health 40:366–386.
Bechtold WE, Lucier G, Birnbaum LS, Yin SN, Li GL, Henderson RF. 1991. Muconic acid determinations in urine as a biological exposure index for workers occupationally exposed to benzene. Am Ind Hyg Assoc J 52:473–478.
Bechtold WE, Sun JD, Birnbaum LS, Yin S-N, Li G-L, Kasicki S, Lucier G, Henderson RF. 1992a. S-phenylcysteine formation in hemoglobin as a biological exposure index to benzene. Arch Toxicol 66:303–309.
Bechtold WE, Willis JK, Sun JD, Griffith WC, Reddy TV. 1992b. Biological markers of exposure to benzene: S-phenylcysteine in albumin. Carcinogenesis 13:1217–1220.
Bogadi-Sare A, Turk R, Zavalic M. 1995. Medical surveillance studies of workers exposed to low level benzene. Arh Hig Rada Toksikol 46:391–398.
Bonassi S, Abbondandolo A, Camurri L, Dal Pra L, De Ferrari M, Degrassi F, Lamberti AF, Lando C, Padovani P, Sbrana I, Vecchio D, Puntoni R. 1995. Are chromosome aberrations in circulating lymphocytes predictive of future cancer onset in humans? Cancer Genet Cytogenet 79:133–135.
Boogaard PJ, van Sittert NJ. 1995. Biological monitoring of exposure to benzene: A comparison between S-phenylmercapturic acid, trans, trans-muconic acid, and phenol. Occup Environ Med 52(9):611–620.
Boogaard PJ, van Sittert NJ. 1996. Suitability of S-phenyl mercapturic acid and trans-trans-muconic acid as biomarkers for exposure to low concentrations of benzene. Environ Health Perspect 104 (Suppl 6):1151–1157.
Brandeau MT, Ducos P, Gaudin R, Morel G, Bonnet P, de Ceaurriz J. 1992. Evaluation of the interaction of benzene and toluene on the urinary excretion of t,t-muconic acid in rats. Toxicol Lett 61(2–3):311–316.
Carrano AV, Natarajan AT. 1988. Considerations for population monitoring using cytogenetic techniques. Mutat Res 204:379–406.
CONCAWE. 1996. Scientific basis for an air quality standard on benzene. Conservation of Clean Air and Water in Western Europe, Brussels, 96/63.
Conforti-Froes N, El-Zein R, Abdel-Rahman SZ, Zwischenberger JB, Au WW. 1997. Predisposing genes and increased chromosome aberrations in lung cancer cigarette smokers. Mutat Res 3799:53–59.
Conover WJ, Iman R. 1981. Rank transformations as a bridge between parametric and nonparametric statistics. Am Stat 35:124–129.
Cooke HJ, Hindley J. 1979. Cloning of human satellite III DNA: Different components are on different chromosomes. Nucleic Acids Res 6:3177–3197.
Ding X, Li Y, Ding Y, Yang H. 1983. Chromosome changes in patients with chronic benzene poisoning. Chin Med J 96:681–685.
Dor F, Dab W, Empereur-Bissonnet P, Zmirou D. 1999 Validity of biomarkers in environmental health studies:The case of PAHs and benzene. Crit Rev Toxicol 29:129–168.
Dosemeci M, Li G-L, Hayes RB, Yin S-N, Linet M, Chow WH, Wang Y-Z, Jiang Z-L, Dai T-R, Zhang W-U, Chao X-J, Ye P-Z, Kou Q-R, Fan Y-H, Zhang X-C, Lin X-F, Meng J-F, Zho J-S, Wacholder S, Kneiler R, Blot WJ. 1994. Cohort study among workers exposed to benzene in China: II. Exposure assessment. Am J Ind Med 26:401–411.
Ducos P, Gaudin R, Bel J, Maire C, Francin JM, Robert A, Wild P. 1992. trans,trans-Muconic acid, a reliable biological indicator for the detection of individual benzene exposure down to the ppm level. Int Arch Occup Environ Health 64:309–313.
Ducos P, Gaudin R, Robert A, Francis JM, Maire C. 1990. Improvement in HPLC analysis of urine t,t-muconic acid, a promising substitute for phenol in the assessment of benzene exposure. Int Arch Occup Environ Health 62:529–534.
Eastmond DA. 1993. Induction of micronuclei and aneuploidy by the quinone-forming agents benzene and o-phenylphenol. Toxicol Lett 67:105–118.
Eastmond DA, Pinkel D. 1990. Detection of aneuploidy and aneuploidy-inducing agents in human lymphocytes using fluorescence in situ hybridization with chromosome-specific DNA probes. Mutat Res 234:303–318.
Eastmond DA, Rupa DS. 1995. Fluorescence in situ hybridization: application to environmental mutagenesis. In: Phillips DH, Venitt S, eds. Environmental Mutagenesis. Oxford, UK: Bios Scientific Publications, pp. 261–290.
Eastmond DA, Rupa DS, Hasegawa LS. 1994. Detection of hyperdiploidy and chromosome breakage in interphase human lymphocytes following exposure to the benzene metabolite hydroquinone using multicolor fluorescence in situ hybridization with DNA probes. Mutat Res 322:9–20.
Eastmond DA, Schuler M, Frantz C, Chen H, Parks R, Wang L, Hasegawa L. 2001. Characterization and Mechanisms of Chromosomal Alterations Induced by Benzene in Mice and Humans. HEI Research Report 103. Cambridge MA: Health Effects Institute.
Eastmond DA, Schuler M, Rupa DS. 1995. Advantages and limitations of using fluorescence in situ hybridization for the detection of aneuploidy in interphase human cells. Mutat Res 348:153–162.
Ehrenberg L, Hiesche KD, Osterman-Golkar S, Wennberg I. 1974. Evaluation of genetic risks of alkylating agents: tissue doses in the mouse from air contaminated with ethylene oxide. Mutat Res 24:83–103.
Eller PM. 1984. Method 1501. In: NIOSH Manual of Analytical Methods (3rd ed). Publ 84-100. Cincinnati OH: U.S. Department of Health and Human Services.
Fleiss JL. 1986. The Design and Analysis of Clinical Experiments. New York NY: John Wiley & Sons.
Forni A. 1979. Chromosome changes and benzene exposure: a review. Rev Environ Health 3:5–7.
Forni A, Cappellini A, Pacifico E, Vigliani EC. 1971. Chromosome changes and their evolution in subjects with past exposure to benzene. Arch Environ Health 23:385–391.
Gad-El Karim MM, Ramanujam VM, Legator MS. 1985. trans,trans-Muconic acid, an open-chain urinary metabolite of benzene in mice: Quantification by high-pressure liquid chromatography. Xenobiotica 15:211–220.
Ghittori S, Imbriani M, Maestri L, Capodaglio E, Cavalleri A. 1999. Determination of S-phenylmercapturic acid in urine as an indicator of exposure to benzene. Toxicol Lett 108:329–334.
Ghittori S, Maestri L, Fiorentino ML, Imbriani M. 1995. Evaluation of occupational exposure to benzene by urinalysis. Int Arch Occup Environ. Health 67:195–200.
Ghittori S, Maestri L, Rolandi L, Lodola L, Fiorentino ML, Imbriani M. 1996. The determination of trans,trans-muconic acid in urine as an indicator of occupational exposure to benzene. Appl Occup Environ Hyg 11:187–191.
Goldstein BD. 1977. Hematotoxicity in humans. J Toxicol Environ Health 2(Suppl):69–105.
Goldstein BD. 1988. Benzene toxicity. Occup Med 3:541–554.
Goldwater LJ. 1941. Disturbances in the blood following exposure to benzol. J Lab Clin Med 26:957–973.
Gray JW, Pinkel D. 1992. Molecular cytogenetics in human cancer diagnosis. Cancer 69(Suppl):1536–1542.
Hagmar L, Bonassi S, Stromberg U, Brogger A, Knudsen LE, Norppa H, Reuterwall C. 1998. Chromosomal aberrations in lymphocytes predict human cancer: A report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH). Cancer Res 58:4117–4121.
Hagmar L, Brogger A, Hansteen I-L, Heim S, Hogstedt B, Knudsen L, Lambert B, Linnainmaa K, Mitelman F, Nordenson I, Reuterwall C, Salomaa S, Skerfving S, Sorsa M. 1994. Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. Cancer Res 54:2919–2922.
Haley NJ, Axelrad CM, Tilton K. 1983. Validation of self-reported smoking behavior: Biochemical analyses of cotinine and thiocyanate. Am J Public Health 73:1204–1207.
Hanway R, Cavicchioli A, Kaur B, Parsons J, Lamb JH, Buckberry LD, Farmer PB. 2000. Analysis of S-phenyl-L-cysteine in globin as marker of benzene exposure. Biomarkers 4:252–262.
Hasegawa LS, Rupa DS, Eastmond DA. 1995. A method for the rapid generation of alpha- and classical satellite probes for human chromosome 9 by polymerase chain reaction using genomic DNA and their application to detect chromosomal alterations in interphase cells. Mutagenesis 10:471–476.
Henderson RF, Sabourin PJ, Bechtold WE, Griffith WC, Medinsky MA, Birnbaum LS, Lucier GW. 1989. The effect of dose, dose rate, route of administration, and species on tissue and blood levels of benzene metabolites. Environ Health Perspect 82:9–17.
Hernberg S, Savilahti M, Ahlman K, Asp S. 1966. Prognostic aspects of benzene poisoning. Br J Ind Med 23:204–209.
Hotz P, Carbonnelle P, Haufroid V, Tschopp A, Buchet JP, Lauwerys R. 1997 Biological monitoring of vehicle mechanics and other workers exposed to low concentrations of benzene. Int Arch Occup Environ Health 70:29–40.
Ikeda M, Inoue O. 1995. Determination of phenolic metabolites and t,t-muconic acid in urine of benzene-exposed workers. In: Advances in Occupational Medicine and Rehabilitation Vol. 1, No. 2, pp. 201–207. Fondazione Salvatore Maugeri Edizioni, Pavia, Italy.
Inoue O, Seiji K, Kasahara M, Nakatsuka H, Watanabe T, Yin SG, Li GL, Cai SX, Jin C, Ikeda M. 1988b. Determination of catechol and quinol in the urine of workers exposed to benzene. Br J Ind Med 45(7):487–492.
Inoue O, Seiji K, Nakatsuka H, Watanabe T, Yin S-N, Li G-L, Cai S-X, Jin C, Ikeda M. 1989a. Urinary t,t-muconic acid as an indicator of exposure to benzene. Brit J Ind Med 46:122–127.
Inoue O, Seiji K, Nakatsuka H, Watanabe T, Yin S-N, Li G-L, Cai S-X, Jin C, Ikeda M. 1989b. Excretion of 1,2,4-benzenetriol in the urine of workers exposed to benzene. Br J Ind Med 46:559–565.
Inoue O, Seiji K, Watanabe T, Kasahara M, Nakatsuka H, Yin SN, Li GL, Cai SX, Jin C, Ikeda M. 1988a. Mutual metabolic suppression between benzene and toluene in man. Int Arch Occup Environ Health 60:15–20.
International Agency for Research on Cancer. 1982. Benzene. In: Some Industrial Chemicals and Dyestuffs, pp. 93–148. IARC Monographs on the Evaluation of Carcinogenic Risk to Humans Vol 29. Lyon, France: IARC.
International Agency for Research on Cancer. 1997. Workshop report. In: Application of Biomarkers in Cancer Epidemiology, pp 1–18. IARC Scientific Publications 142. Lyon, France: IARC.
Johnson ES, Lucier G. 1992. Perspectives on risk assessment impact of recent reports on benzene. Am J Ind Med 21:749–757.
Khuder SA, Youngdale MC, Bisesi MS, Schaub EA. 1999. Assessment of complete blood count variations among workers exposed to low levels of benzene. J Occup Environ Med 41:821–826.
Kipen, HM, Cody RP, Goldstein BD. 1989. Use of longitudinal analysis of peripheral blood counts to validate historical reconstructions of benzene exposure. Environ Health Perspect 82:199–206.
Kivisto H, Pekari K, Peltonen K, Svinhufvud J, Veidebaum T, Sorsa M, Aitio A. 1997. Biological monitoring of exposure to benzene in the production of benzene and in a cokery. Sci Total Environ 199:49–63
LaMontagne AD, Christiani DC, Kelsey KT. 1993. Utility of the complete blood count in routine medical surveillance for ethylene oxide exposure. Am J Ind Med 24:191–206.
Lee BL, Ong HY, Shi CY, Ong CN. 1993. Simultaneous determination of hydroquinone, catechol and phenol in urine using high-performance liquid chromatography with fluorimetric detection. J Chromatogr 619:259–266.
Lindstrom AB, Yeowell-O'Connell K, Waidyanatha S,McDonald TA, Golding BT, Rappaport SM. 1998. Formation of hemoglobin and albumin adducts of benzene oxide in mouse, rat, and human blood. Chem Res Toxicol 11:302–310.
Liniecki J, Bajerska A, Gluszczowa M. 1971. Analiza kariologiczna limfocytow krwi obwodowej u osob z przebytym przewleklym zatruciem benzenem. Medycyna Pracy 22:187–193.
Maestri L. 1995. Determination of hemoglobin adductsformed by benzene exposure. In: Advances in Occupational Medicine and Rehabilitation Vol. 1, No. 2, pp. 219–229. Fondazione Salvatore Maugeri Edizioni, Pavia, Italy.
Major J, Jakab M, Kiss G, Tompa A. 1994. Chromosome aberration, sister-chromatid exchange, proliferative rate index, and serum thiocyanate concentration in smokers exposed to low-dose benzene. Environ Mol Mutagen 23:137–142.
Marcon F, Zijno A, Crebelli R, Carere A, Schuler M, Parks R, Eastmond DA. 1997. Detection of cytogenetic damages in blood cells of benzene-exposed workers by multicolor fluorescence in situ hybridization (FISH). Mutat Res 379:S141, XIV C.23.
Marcon F, Zijno A, Crebelli R, Carere A, Veidebaum T, Peltonen K, Parks R, Schuler M, Eastmond DA. 1999. Chromosome damage and aneuploidy detected by interphase multicolour FISH in benzene-exposed shale oil workers. Mutat Res 445:155–166.
Martin RH, Ernst S, Rademaker A, Barclay L, Ko E, Summers N. 1997. Chromosomal abnormalities in sperm from testicular cancer patients before and after chemotherapy. Hum Genet 99:214–218.
McDonald TA, Waidyanatha S, Rappaport SM. 1993. Measurement of adducts of benzoquinone with hemoglobin and albumin. Carcinogenesis 14(9):1927–1932.
Melikian AA, Meng M, O'Connor R, Hu P, Thompson SM. 1999a. Development of Liquid Chromatography–Electrospray Ionization–-Tandem Mass Spectrometry Methods for Determination of Urinary Metabolites of Benzene in Humans. Research Report 87. Cambridge MA: Health Effects Institute.
Melikian AA, O'Connor R, Prahalad AK, Hu P, Li H, Kagan M, Thompson S. 1999b. Determination of urinary benzene metabolites S-phenylmercapturic acid and trans,trans-muconic acid by liquid chromatography-tandem mass spectrometry. Carcinogenesis 20:719–726.
Melikian AA, Prahalad AK, Coleman S. 1992. Isolation and characterization of the two benzene-derived hemoglobin adducts in vivo in rats. Cancer Epidemiol Biomarkers Prev 1:307–313.
Melikian AA, Prahalad AK, Hoffmann, D. 1993. Urinary trans,trans-muconic acid as an indicator of exposure to benzene in cigarette smokers. Cancer Epidemiol Biomarkers Prev 2:47–51.
Melikian AA, Prahalad AK, Secker-Walker RH. 1994. Comparison of levels of urinary benzene metabolite trans, trans-muconic acid in smokers and nonsmokers, and the effects of pregnancy. Cancer Epidemiol Biomarkers Prev 3:239–244.
Ong CN, Kok PW, Lee BL, Shi CY, Ong HY, Chia KS, Lee CS, Luo XW. 1995. Evluation of biomarkers of occupational exposure to benzene. Occup Environ Med 52:528–533.
Ong CN, Kok PW, Ong HY, Shi CY, Lee BL, Phoon WH, Tan KT. 1996. Biomarkers of exposure to low concentrations of benzene: A field assessment. Occup Environ Med 53:328–333.
Ong CN, Lee BL. 1994. Determination of benzene and its metabolites: Application in biological monitoring of environmental and occupational exposure to benzene. J Chromatogr B Biomed Appl 660:1–22.
Osterman-Golkar S, Christakopoulos A, Segerback D, Hallstrom I. 1976. Evaluation of genetic risks of alkylating agents II: hemoglobin as a dose monitor. Mutat Res 34:1–10.
Pekari K. 1995. Biological monitoring of occupational exposure to low levels of benzene. In: Advances in Occupational Medicine and Rehabilitation Vol. 1, No. 2, pp. 145–154. Fondazione Salvatore Maugeri Edizioni, Pavia, Italy.
Pezzagno G, Maestri L. 1997. The specifics of trans, trans-muconic acid as a biological indicator for low levels of environmental benzene. Indoors Built Environ 6:12–18.
Pezzagno G, Maestri L, Fiorentino ML. 1999. trans, trans-Muconic acid, a biological indicator to low levels of environmental benzene: Some aspects of its specificity. Am J Ind Med 35(5):511–518.
Pollini G, Biscaldi GP. 1976. Persistenza delle alterazioni del cariotipo nei linfociti di soggetti benzolici a dieci anni dalla intossicazione. Med Lav 67:465–472.
Pollini G, Biscaldi GP, Robustelli Della Cuna G. 1969. [Chromosome changes of the lymphocytes discovered after five years in subjects with benzolic hemopathy.] Med Lav 60:743–758.
Popp W, Rauscher D, Muller G, Angerer J, Norpoth K. 1994. Concentrations of benzene in blood and S-phenylmercapturic acid and t,t-muconic acid in urine in car mechanics. Int Arch Occup Environ Health 66:1–6.
Qu QS, Melikian AA, Li G, Shore R, Chen LC, Cohen B, Yin S, Kagan M, Li H, Meng M, Jin X, Winnik W, Li Y, Mu R, Li K. 2000. Validation of biomarkers in humans exposed to benzene: I. Urine metabolites. Am J Ind Med 37:522–531.
Ramirez MJ, Surralles J, Galofre P, Creus A, Marcos R. 1997. Radioactive iodine induces clastogenic and age-dependent aneugenic effects in lymphocytes of thyroid cancer patients as revealed by interphase FISH. Mutagenesis 12:449–455.
Rappaport SM, Yeowell-O’Connell K. 1999. Protein adducts as dosimeters of human exposure to styrene, styrene-7,8-oxide and benzene. Toxicol Lett 108:117–126.
Robbins WA, Baulch JE, Moore D, Weier HU, Blakey D, Wyrobek AJ. 1995. Three-probe fluorescence in situ hybridization to assess chromosome X, Y, and 8 aneuploidy in sperm of 14 men from two healthy groups: Evidence for a paternal age effect on sperm aneuploidy. Reprod Fertil Dev 7:799–809.
Robbins WA, Vine MF, Truong KY, Everson RB. 1997. Use of fluorescence in situ hybridization (FISH) to assess effects of smoking, caffeine, and alcohol on aneuploidy load in sperm of healthy men. Environ Mol Mutagen 30:175–183.
Rothman N, Li G, Dosemeci M, Bechtold WE, Marti GE, Wang Y, Linet M, Xi L, Lu W, Smith MT, Titenko-Holand N, Zhang L, Blot W, Yin S, Hayes R. 1996. Hematotoxicity among Chinese workers heavily exposed to benzene. Am J Ind Med 29:236–246.
Rump P. 1981. Darstellung, Charakterisierung und Trennung der Mercaptursäurea von Benzol, Totuol, Aethylbenzol und Xylolen Durch GC-MS-Analyse [dissertation], pp. 20–25. University of Hamburg, Hamburg, Germany.
Rupa DS, Eastmond DA. 1997. Chromosomal alterations affecting the 1cen-1q12 region in buccal mucosal cells of betel quid chewers detected using multicolor fluorescence in situ hybridization. Carcinogenesis 18:2347–2351.
Rupa DS, Hasegawa L, Eastmond DA. 1995. Detection of chromosomal breakage in the 1 cen-1q12 region of interphase human lymphocytes using multicolor fluorescence in situ hybridization with tandem DNA probes. Cancer Res 55:640–645.
Rupa DS, Schuler M, Eastmond DA. 1997. Detection of hyperdiploidy and breakage affecting the 1cen-1q 12 region of cultured interphase human lymphocytes treated with various genotoxic agents. Environ Mol Mutagen 29:161–167.
Ruppert T, Scherer G, Tricker AR, Adlkofer F. 1997. trans,trans-Muconic acid as a biomarker of non-occupational environmental exposure to benzene. Int Arch Occup Environ Health 69:247–251.
Ruppert T, Scherer G, Tricker AR, Rauscher D, Adlkofer F. 1995. Determination of urinary trans,trans-muconic acid by gas chromatography–mass spectrometry. J Chromatogr B Biomed Sci Appl 666:71–76.
Sabourin PJ, Sun JD, Birnbaum LS, Lucier G, Henderson RF. 1989. Effect of repeated benzene inhalation exposures on subsequent metabolism of benzene. Exp Pathol 37:155–157.
Sarto F, Cominato I, Pinton AM, Brovedani PG, Merler E,Peruzzi M, Bianchi V, Levis AG. 1984. A cytogenetic study on workers exposed to low concentrations of benzene. Carcinogenesis 5:827–832
SAS. 2000. SAS Statistical System. SAS Institute, Cary NC.
Sato A, Nakajima T. 1979. Dose-dependent metabolic interaction between benzene and toluene in vivo and in vitro. Toxicol Appl Pharmacol 48:249–256.
Schuler M, Hasegawa L, Parks R, Metzler M, Eastmond DA. 1998. Dose-response studies of the induction of hyperdiploidy and polyploidy by diethylstilbestrol and 17betaestradiol in cultured human lymphocytes using multicolor fluorescence in situ hybridization. Environ Mol Mutagen 31:263–273.
Smith MT, Zhang L, Wang Y, Hayes RB, Li G, Wiemels J, Dosemeci M, Titenko-Holland N, Xi L, Kolachana P, Yin S, Rothman N. 1998. Increased translocations and aneusomy in chromosomes 8 and 21 among workers exposed to benzene. Cancer Res 58:2176–2181.
Sorsa M, Wilbourn J, Vainio H. 1992. Human cytogenetic damages as a predictor of cancer risk. In: Vainio H, Magee PN, McGregor DB, McMichael AJ, eds. Mechanisms of Carcinogenesis in Risk Identification. IARC Scientific Publications 116. Lyon, France: International Agency for Research on Cancer, pp. 543–554.
SPSS. 1994. Base system user’s guide; Syntax reference guide; Advanced statistics. In: SPSS for Windows, Release 6.1 (Norusis M, ed). SPSS, Chicago IL.
Stommel P, Muller G, Stucker W, Verkoyen C, Schobel S, Norpoth K. 1989. Determination of S-phenylmercapturic acid in the urine: an improvement of the biological monitoring of benzene exposure. Carcinogenesis 10:279–282.
Surralles J, Autio k, Nylund L, Jarventaus H, Norppa H, eidebaum T, Sorsa M, Peltonen K. 1997a. Molecular cytogenetic analysis of buccal cells and lymphocytes from benzene-exposed workers. Carcinogenesis 18:817–823.
Surralles J, Darroudi F, Natarajan AT. 1997b. Low level of DNA repair in human chromosome 1 heterochromatin. Genes Chromosom Cancer 20:173–184.
Tagarro I, Fernandez-Peralta AM, Gonzalez-Aguilera JJ. 1994. Chromosomal localization of human satellites 2 and 3 by a FISH method using oligonucleuotides as probes. Hum Genet 93:383–388.
Tompa A, Major J, Jakab M. 1994. Monitoring of benzene-exposed workers for genotoxic effects of benzene: Improved-working-condition-related decrease in the frequencies of chromosome aberrations in peripheral blood lymphocytes. Mutat Res 304:159–165.
Trask B, Pinkel D. 1990. Fluorescence in situ hybridization with DNA probes. Methods Cell Biol 33:383–400.
Troester MA, Lindstrom AB, Kupper LL, Waidyanatha S, Rappaport SM. 2000. Stability of hemoglobin and albumin adducts of benzene oxide and 1,4-benzoquinone after administration of benzene to F344 rats. Toxicol Sci 54:88–94.
Tucker JD, Eastmond DA, Littlefield LG. 1997. Cytogenetic end-points as biological dosimeters and predictors of risk in epidemiological studies. In: Application of Biomarkers in Cancer Epidemiology, IARC Scientific Publications 142. Lyon, France: International Agency for Research on Cancer, pp. 185–200.
Turkel B, Egeli U. 1994. Analysis of chromosomal aberrations in shoe workers exposed long term to benzene. Occup Environ Med 51:50–53.
van Sittert NJ, Boogaard PJ, Beulink GDJ. 1993. Application of urinary S-phenylmercapturic acid test as a biomarker for low levels of exposure to benzene in industry. Brit J Ind Med 50:460–469.
Vogel E, Gunther H. 1967. Benzeoxide-oxepin valence tautomerism. Agnew Chem Int Edit Engl 6:385–401.
Waidyanatha S, Yeowell-O’Connell K, Rappaport SM. 1998. A new assay for albumin and hemoglobin adducts of 1,2- and 1,4- benzoquinones. Chem Biol Interact 115(2):117–139.
Wallace L. 1996. Environmental exposure to benzene: An update. Environ Health Perspect 104(Suppl 6):1129–1136.
Ward CO, Kuna RA, Snyder NK, Alsaker RD, Coate WB, Craig PH. 1985. Subchronic inhalation toxicity of benzene in rats and mice. Am J Ind Med 7:457–473.
Ward E, Hornung R, Morris J, Rinsky R, Wild D, HalperinW, Guthrie W. 1996. Risk of low red or white blood cell count related to estimated benzene exposure in a rubber-worker cohort (1940–1975). Am J Ind Med 29:247–257.
World Health Organization. 1993. Biomarkers and Risk Assessment: Concepts and Principles. WHO Environmental Health Criteria 155. World Health Organization, Geneva, Switzerland.
Witz G, Maniara W, Mylavarapu V, Goldstein BD. 1990. Comparative metabolism of benzene and trans,trans-muconaldehyde to trans,trans-muconic acid in DBA/2N and C57BL/6 mice. Biochem Pharmacol 40(6):1275–1280.
Witz G, Zhang Z, Goldstein BD. 1996. Reactive ring-opened aldehyde metabolites in benzene hematotoxicity. Environ Health Perspect 104(Suppl 6):1195–1199.
Yardley-Jones A, Andweson D, Park DV. 1991. The toxicity of benzene and its metabolism and molecular pathology in human risk assessment. Br J Ind Med 48:437–444.
Yeowell-O’Connell K, Rothman N, Smith MT, Hayes RB, Li G, Waidyanatha S, Dosemeci M, Zhang L, Yin S, TitenkoHolland N, Rappaport SM. 1998. Hemoglobin and albumin adducts of benzene oxide among workers exposed to high levels of benzene. Carcinogenesis 19:1565–1571.
Yu R, Weisel CP. 1996. Measurement of the urinary benzene metabolite trans,trans-muconic acid from benzene exposure in humans. J Toxicol Environ Health 48:453–477.
Zar JH. 1984. Biostatistical Analysis (2nd ed). Englewood Cliffs NJ: Prentice-Hall.
Zhang L, Rothman N, Wang Y, Hayes RB, Bechtold W, Ven-katesh P, Yin S, Wang Y, Dosemeci M, Li G, Lu W, Smith MT. 1996. Interphase cytogenetics of workers exposed to benzene. Environ Health Perspect 104(Suppl6):1325–1329.
Zhang L, Rothman N, Wang Y, Hayes RB, Li G, Dosemeci M, Yin S, Kolachana P, Titenko-Holland N, Smith MT. 1998. Increased aneusomy and long arm deletion of chromosomes 5 and 7 in the lymphocytes of Chinese workers exposed to benzene. Carcinogenesis 19:1955–1961.
Journal Articles on this Report : 4 Displayed | Download in RIS Format
|Other subproject views:||All 5 publications||5 publications in selected types||All 4 journal articles|
|Other center views:||All 12 publications||12 publications in selected types||All 7 journal articles|
||Melikian AA, Qu Q, Shore R, Li G, Li H, Jin X, Cohen B, Chen L, Li Y, Yin S, Mu R, Zhang X, Wang Y. Personal exposure to different levels of benzene and its relationships to the urinary metabolites S-phenylmercapturic acid and trans, trans-muconic acid. Journal of Chromatography B:Analytical Technologies in the Biomedical and Life Sciences 2002;778(1-2):211-221.||
||Qu QS, Melikian AA, Li G, Shore R, Chen LC, Cohen B, Yin S, Kagan MR, Li H, Meng M, Jin X, Winnik W, Li Y, Mu R, Li K. Validation of biomarkers in humans exposed to benzene: urine metabolites. American Journal of Industrial Medicine 2000;37(5):522-531.||
||Qu Q, Shore R, Li G, Jin X, Chen LC, Cohen B, Melikian AA, Eastmond D, Rappaport SM, Yin S, Li H, Waidyanatha, S, Li Y, Mu R, Zhang X, Li K. Hematological changes among Chinese workers with a broad range of benzene exposures. American Journal of Industrial Medicine 2002;42(4):275-285.||
||Rappaport SM, Waidyanatha S, Qu Q, Shore R, Jin X, Cohen B, Chen L-C, Melikian AA, Li G, Yin S, Yan H, Xu B, Mu R, Li Y, Zhang X, Li K. Albumin adducts of benzene oxide and 1,4-benzoquinone as measures of human benzene metabolism. Cancer Research 2002;62(5):1330-1337.||
Supplemental Keywords:Health Effects, Air Toxics, Toxicology, exposure-response, Biology
Progress and Final Reports:Original Abstract
Main Center Abstract and Reports:R828112 Health Effects Institute (2000 — 2005)
Subprojects under this Center: (EPA does not fund or establish subprojects; EPA awards and manages the overall grant for this center).
R828112C042 Does Inhalation of Methanol Vapor Affect Human Neurobehavior?
R828112C043 Human Responses to Nitrogen Dioxide
R828112C044 The Role of Inflammation in Ozone-Induced Lung Injury
R828112C045 How Does Exercise Affect the Dose of Inhaled Air Pollutants?
R828112C046 How Do Chemicals in Diesel Engine Exhaust Damage DNA?
R828112C047 Effect of Nitrogen Dioxide on Bacterial Respiratory infection in Mice
R828112C048 Effects of Ozone Exposure on Airway Epithelium
R828112C049 Inhalation of Aldehydes and Effects on Breathing
R828112C050 Does Ozone Cause Precancerous Changes in Cells?
R828112C051 Effects of Formaldehyde on Human Airway Epithelial Cells Exposed in a Novel Culture System
R828112C052 Carbon Monoxide and Cardiac Arrhythmias
R828112C053 Effects of Formaldehyde and Particle-Bound Formaldehyde on Lung Macrophage Functions
R828112C054 Mechanisms for Protecting Lung Epithelial Cells Against Oxidant Injury
R828112C055 Relationship of Nitropyrene-Derived DNA Adducts to Carcinogenesis
R828112C056 Particle Trap Effects on Heavy-Duty Diesel Engine Emissions
R828112C057 Carbon Monoxide and Atherosclerosis
R828112C058 Nitrogen Dioxide and Respiratory Illness in Children
R828112C059 Noninvasive Methods for Measuring Ventilation in Mobile Subjects
R828112C060 Oxidant Air Pollutants and Lung Cancer: An Animal Model
R828112C061 Detection of Carcinogen-DNA Adducts: Development of New Methods
R828112C062 Effects of Carbon Monoxide on Heart Muscle Cells
R828112C063 Development of Personal Ozone Samplers: Three Approaches
R828112C064 Development of Biomarkers to Monitor Carcinogen Exposure
R828112C065 Effects of Prolonged Ozone Inhalation on Collagen Structure and Content in Rat Lungs
R828112C065II Prolonged Ozone Exposure and the Contractile Properties of Isolated Rat Airways
R828112C065III Changes in Complex Carbohydrate Content and Structure in Rat Lungs Caused by Prolonged Ozone Inhalation
R828112C065IV Genetic Control of Connective Tissue Protein Synthesis After Prolonged Ozone Inhalation
R828112C065V Pulmonary Function Alterations in Rats After Chronic Ozone Inhalation
R828112C065VII Prolonged Ozone Exposure Leads to Functional and Structural Changes in the Rat Nose
R828112C065VIII - IX Studies of Changes in Lung Structure and Enzyme Activitiesin Rats After Prolonged Exposure to Ozone
R828112C065X An Innovative Approach to Analyzing Multiple Experimental Outcomes: A Case Study of Rats Exposed to Ozone
R828112C065XI The Consequences of Prolonged Inhalation of Ozone on Rats: An Integrative Summary of the Results of Eight Collaborative Studies
R828112C066 Interactive Effects of Nitropyrenes in Diesel Exhaust
R828112C067 Detection of FormaldehydeDNA Adducts: Development of New Methods
R828112C068I Comparison of the Carcinogenicity of Diesel Exhaust and Carbon Black in Rat Lungs
R828112C068II An Investigation of DNA Damage in the Lungs of Rats Exposed to Diesel Exhaust
R828112C068III No Evidence For Genetic Mutations Found In Lung Tumors From Rats Exposed To Diesel Exhaust or Carbon Black
R828112C069 Noninvasive Determination of Respiratory Ozone Absorption: The Bolus-Response Method
R828112C070 The Effects of Inhaled Oxidants and Acid Aerosols on Pulmonary Function
R828112C071 Biochemical Consequences of Ozone Reacting with Membrane Fatty Acids
R828112C072 DNA Mutations in Rats Treated with a Carcinogen Present in Diesel Exhaust
R828112C073 Developmental Neurotoxicity of Inhaled Methanol in Rats
R828112C074 Methanol Distribution in Non Pregnant and Pregnant Rodents
R828112C075 Is Increased Mortality Associated with Ozone Exposure in Mexico City?
R828112C076 Effects of Fuel Modification and Emission Control Devices on Heavy-Duty Diesel Engine Emissions
R828112C077 Metabolic Studies in Monkeys Exposed to Methanol Vapors
R828112C078 Effects of Ozone on Pulmonary Function and Airway Inflammation in Normal and Potentially Sensitive Human Subjects
R828112C079 Improvement of a Respiratory Ozone Analyzer
R828112C080 Mechanism of Oxidative Stress from Low Levels of Carbon Monoxide
R828112C081 Long-Term Exposure to Ozone: Development of Methods to Estimate Past Exposures and Health Outcomes
R828112C082 Effects of Ambient Ozone on Healthy, Wheezy, and Asthmatic Children
R828112C083 Daily Changes in Oxygen Saturation and Pulse Rate Associated with Particulate Air Pollution and Barometric Pressure
R828112C084 Evaluation of The Potential Health Effects of the Atmospheric Reaction Products of Polycyclic Aromatic Hydrocarbons
R828112C085 Mechanisms of Response to Ozone Exposure: The Role of Mast Cells in Mice
R828112C086 Statistical Methods for Epidemiologic Studies of the Health Effects of Air Pollution
R828112C087 Development of New Methods to Measure Benzene Biomarkers
R828112C088 Alveolar Changes in Rat Lungs After Long-Term Exposure to Nitric Oxide
R828112C089 Effects of Prenatal Exposure to Inhaled Methanol on Nonhuman Primates and Their Infant Offspring
R828112C090 A Pilot Study of Potential Biomarkers of Ozone Exposure
R828112C091 Effects of Concentrated Ambient Particles on the Cardiac and Pulmonary Systems of Dogs
R828112C092 Cancer, Mutations, and Adducts in Rats and Mice Exposed to Butadiene and Its Metabolites
R828112C093 Effects of Concentrated Ambient Particles in Rats and Hamsters: An Exploratory Study
R828112C094I The National Morbidity, Mortality, and Air Pollution Study: Methods and Methodologic Issues
R828112C094II The National Morbidity, Mortality, and Air Pollution Study: Morbidity and Mortality from Air Pollution in the United States
R828112C095 Association of Particulate Matter Components with Daily Mortality and Morbidity in Urban Populations
R828112C096 Acute Pulmonary Effects of Ultrafine Particles in Rats and Mice
R828112C097 Identifying Subgroups of the General Population That May Be Susceptible to Short-Term Increases in Particulate Air Pollution
R828112C098 Daily Mortality and Fine and Ultrafine Particles in Erfurt, Germany
R828112C099 A Case-Crossover Analysis of Fine Particulate Matter Air Pollution and Out-of-Hospital Sudden Cardiac Arrest
R828112C100 Effects of Mexico City Air on Rat Nose
R828112C101 Penetration of Lung Lining and Clearance of Particles Containing Benzo[a]pyrene
R828112C102 Metabolism of Ether Oxygenates Added to Gasoline
R828112C103 Characterization and Mechanisms of Chromosomal Alterations Induced by Benzene in Mice and Humans
R828112C104 Acute Cardiovascular Effects in Rats from Exposure to Urban Ambient Particles
R828112C105 Genetic Differences in Induction of Acute Lung Injury and Inflammation in Mice
R828112C106 Effects on Mice of Exposure to Ozone and Ambient Particle Pollution
R828112C107 Emissions from Diesel and Gasoline Engines Measured in Highway Tunnels
R828112C108 Case-Cohort Study of Styrene Exposure and Ischemic Heart Disease Investigators
R828112C110 Effects of Metals Bound to Particulate Matter on Human Lung Epithelial Cells
R828112C111 Effect of Concentrated Ambient Particulate Matter on Blood Coagulation Parameters in Rats
R828112C112 Health Effects of Acute Exposure to Air Pollution
R828112C113 Benzene Metabolism in Rodents at Doses Relevant to Human Exposure from Urban Air
R828112C114 A Personal Particle Speciation Sampler
R828112C115 Validation and Evaluation of Biomarkers in Workers Exposed to Benzene in China
R828112C116 Biomarkers in Czech Workers Exposed to 1,3-Butadiene: A Transitional Epidemiologic Study
R828112C117 Peroxides and Macrophages in the Toxicity of Fine Particulate Matter in Rats
R828112C118 Controlled Exposures of Healthy and Asthmatic Volunteers to Concentrated Ambient Particles in Metropolitan Los Angeles
R828112C119 Manganese Toxicokinetics at the Blood-Brain Barrier
R828112C120 Effects of Exposure to Concentrated Ambient Particles from Detroit Air on Healthy Rats and Rats with Features of Asthma or Mild Bronchitis
R828112C121 Field Evaluation of Nanofilm Detectors for Measuring Acidic Particles in Indoor and Outdoor Air
R828112C123 Time-Series Analysis of Air Pollution and Mortality: A Statistical Review
R828112C126 Effects of Exposure to Ultrafine Carbon Particles in Healthy Subjects and Subjects with Asthma
R828112C128 Neurogenic Responses of Rat Lung to Diesel Exhaust
R828112C130-I Relationships of Indoor, Outdoor, and Personal Air (RIOPA). Part I. Collection Methods and Descriptive Analyses
R828112C132 An Updated Study of Mortality Among North American Synthetic Rubber Industry Workers